JP Patent

JP2000500505A — Ｇｌｐ―１誘導体

Assigned to Novo Nordisk AS · Expires 2000-01-18 · 26y expired

What this patent protects

(57)【要約】 親油性置換基を有するGLP−１導体及びその類似体は興味深い薬理特性を有し、特にGLP−１（７−37）よりも遅い作用プロフィールを有する。

USPTO Abstract

(57)【要約】 親油性置換基を有するGLP−１導体及びその類似体は興味深い薬理特性を有し、特にGLP−１（７−37）よりも遅い作用プロフィールを有する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2000500505A
Jurisdiction
JP
Classification
—
Expires
2000-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.